APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Research Report 2026

Report ID 174006740522 December 2025129 pages

Choose your research edition.

Industry ResearchLeber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) include Alkeus Pharmaceuticals, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech, ProQR Therapeutics and Spark Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market in terms of revenue (US$ million) and, where applicable, sales volume (k pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k pcs) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market by Company

Alkeus Pharmaceuticals

Biovista

Editas Medicine

GenSight Biologics

Ixchel Pharma

Khondrion

Mitotech

ProQR Therapeutics

Spark Therapeutics

Stealth BioTherapeutics

Usher Syndrome

Amgen

Sanofi

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type

Dominant Optic Atrophy

Recessive Optic Atrophy

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application

Hospitals

Medical Research Institute

Eye Clinics

Other

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs) of Manufacturers (2021-2026) Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue of Manufacturers (2021-2026) Table 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price (US$/pcs) of Manufacturers (2021-2026) Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Type & Application Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Alkeus Pharmaceuticals Company Information Table 19. Alkeus Pharmaceuticals Business Overview Table 20. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 21. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 22. Alkeus Pharmaceuticals Recent Developments Table 23. Biovista Company Information Table 24. Biovista Business Overview Table 25. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 26. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 27. Biovista Recent Developments Table 28. Editas Medicine Company Information Table 29. Editas Medicine Business Overview Table 30. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 31. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 32. Editas Medicine Recent Developments Table 33. GenSight Biologics Company Information Table 34. GenSight Biologics Business Overview Table 35. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 36. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 37. GenSight Biologics Recent Developments Table 38. Ixchel Pharma Company Information Table 39. Ixchel Pharma Business Overview Table 40. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 41. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 42. Ixchel Pharma Recent Developments Table 43. Khondrion Company Information Table 44. Khondrion Business Overview Table 45. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 46. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 47. Khondrion Recent Developments Table 48. Mitotech Company Information Table 49. Mitotech Business Overview Table 50. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 51. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 52. Mitotech Recent Developments Table 53. ProQR Therapeutics Company Information Table 54. ProQR Therapeutics Business Overview Table 55. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 56. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 57. ProQR Therapeutics Recent Developments Table 58. Spark Therapeutics Company Information Table 59. Spark Therapeutics Business Overview Table 60. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 62. Spark Therapeutics Recent Developments Table 63. Stealth BioTherapeutics Company Information Table 64. Stealth BioTherapeutics Business Overview Table 65. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 67. Stealth BioTherapeutics Recent Developments Table 68. Usher Syndrome Company Information Table 69. Usher Syndrome Business Overview Table 70. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 71. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 72. Usher Syndrome Recent Developments Table 73. Amgen Company Information Table 74. Amgen Business Overview Table 75. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 76. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 77. Amgen Recent Developments Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 81. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 82. Sanofi Recent Developments Table 83. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2021-2026) & (k pcs) Table 85. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2021-2026) Table 86. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2027-2032) & (k pcs) Table 87. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2027-2032) Table 88. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2021-2026) Table 90. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2027-2032) Table 92. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 94. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2027-2032) & (k pcs) Table 95. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 99. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2027-2032) & (k pcs) Table 100. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 104. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2027-2032) & (k pcs) Table 105. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 109. South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2027-2032) & (k pcs) Table 110. South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 114. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2027-2032) & (k pcs) Table 115. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (k pcs) Table 118. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2027-2032) & (k pcs) Table 119. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2021-2026) Table 120. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2027-2032) Table 121. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2021-2026) Table 124. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2027-2032) Table 125. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2021-2026) & (US$/pcs) Table 126. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2027-2032) & (US$/pcs) Table 127. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (k pcs) Table 128. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2027-2032) & (k pcs) Table 129. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2021-2026) Table 130. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2027-2032) Table 131. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2021-2026) Table 134. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2027-2032) Table 135. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2021-2026) & (US$/pcs) Table 136. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2027-2032) & (US$/pcs) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List Table 140. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List Table 141. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends Table 142. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Drivers Table 143. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Image Figure 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size (2021-2032) & (US$ Million) Figure 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2021-2032) & (k pcs) Figure 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price (US$/pcs) & (2021-2032) Figure 9. Dominant Optic Atrophy Product Image Figure 10. Recessive Optic Atrophy Product Image Figure 11. Hospitals Product Image Figure 12. Medical Research Institute Product Image Figure 13. Eye Clinics Product Image Figure 14. Other Product Image Figure 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region in 2025 Figure 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region in 2025 Figure 22. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country in 2025 Figure 23. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2032) Figure 24. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2021-2032) Figure 25. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country in 2025 Figure 29. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2032) Figure 30. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2021-2032) Figure 31. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country in 2025 Figure 42. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2021-2032) Figure 44. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country in 2025 Figure 53. South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2032) Figure 54. South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2021-2032) Figure 55. Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country in 2025 Figure 59. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2021-2032) Figure 61. Egypt Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2021-2032) Figure 67. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2021-2032) Figure 68. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (US$/pcs) by Type (2021-2032) Figure 69. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2021-2032) Figure 70. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2021-2032) Figure 71. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (US$/pcs) by Application (2021-2032) Figure 72. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Value Chain Figure 73. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Dominant Optic Atrophy
  • Recessive Optic Atrophy
Applications
  • Hospitals
  • Medical Research Institute
  • Eye Clinics
  • Other
Companies covered
  • Alkeus Pharmaceuticals
  • Biovista
  • Editas Medicine
  • GenSight Biologics
  • Ixchel Pharma
  • Khondrion
  • Mitotech
  • ProQR Therapeutics
  • Spark Therapeutics
  • Stealth BioTherapeutics
  • Usher Syndrome
  • Amgen
  • Sanofi

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size (2021-2032)
  4. 2.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2021-2032)
  5. 2.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Average Price (2021-2032)
  6. 2.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Dominant Optic Atrophy
  9. 2.3.3 Recessive Optic Atrophy
  10. 2.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospitals
  13. 2.4.3 Medical Research Institute
  14. 2.4.4 Eye Clinics
  15. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs) of Manufacturers (2021-2026)
  3. 3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Type & Application
  8. 3.8 Global Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Established Date
  9. 3.9 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Alkeus Pharmaceuticals
  2. 4.1.1 Alkeus Pharmaceuticals Company Information
  3. 4.1.2 Alkeus Pharmaceuticals Business Overview
  4. 4.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  6. 4.1.5 Alkeus Pharmaceuticals Recent Developments
  7. 4.2 Biovista
  8. 4.2.1 Biovista Company Information
  9. 4.2.2 Biovista Business Overview
  10. 4.2.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  12. 4.2.5 Biovista Recent Developments
  13. 4.3 Editas Medicine
  14. 4.3.1 Editas Medicine Company Information
  15. 4.3.2 Editas Medicine Business Overview
  16. 4.3.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  18. 4.3.5 Editas Medicine Recent Developments
  19. 4.4 GenSight Biologics
  20. 4.4.1 GenSight Biologics Company Information
  21. 4.4.2 GenSight Biologics Business Overview
  22. 4.4.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  24. 4.4.5 GenSight Biologics Recent Developments
  25. 4.5 Ixchel Pharma
  26. 4.5.1 Ixchel Pharma Company Information
  27. 4.5.2 Ixchel Pharma Business Overview
  28. 4.5.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  30. 4.5.5 Ixchel Pharma Recent Developments
  31. 4.6 Khondrion
  32. 4.6.1 Khondrion Company Information
  33. 4.6.2 Khondrion Business Overview
  34. 4.6.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  36. 4.6.5 Khondrion Recent Developments
  37. 4.7 Mitotech
  38. 4.7.1 Mitotech Company Information
  39. 4.7.2 Mitotech Business Overview
  40. 4.7.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  42. 4.7.5 Mitotech Recent Developments
  43. 4.8 ProQR Therapeutics
  44. 4.8.1 ProQR Therapeutics Company Information
  45. 4.8.2 ProQR Therapeutics Business Overview
  46. 4.8.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  48. 4.8.5 ProQR Therapeutics Recent Developments
  49. 4.9 Spark Therapeutics
  50. 4.9.1 Spark Therapeutics Company Information
  51. 4.9.2 Spark Therapeutics Business Overview
  52. 4.9.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  54. 4.9.5 Spark Therapeutics Recent Developments
  55. 4.10 Stealth BioTherapeutics
  56. 4.10.1 Stealth BioTherapeutics Company Information
  57. 4.10.2 Stealth BioTherapeutics Business Overview
  58. 4.10.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  60. 4.10.5 Stealth BioTherapeutics Recent Developments
  61. 4.11 Usher Syndrome
  62. 4.11.1 Usher Syndrome Company Information
  63. 4.11.2 Usher Syndrome Business Overview
  64. 4.11.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  66. 4.11.5 Usher Syndrome Recent Developments
  67. 4.12 Amgen
  68. 4.12.1 Amgen Company Information
  69. 4.12.2 Amgen Business Overview
  70. 4.12.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  72. 4.12.5 Amgen Recent Developments
  73. 4.13 Sanofi
  74. 4.13.1 Sanofi Company Information
  75. 4.13.2 Sanofi Business Overview
  76. 4.13.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  78. 4.13.5 Sanofi Recent Developments
5 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Scenario by Region
  1. 5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2021-2032
  3. 5.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2021-2026
  4. 5.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2027-2032
  5. 5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2021-2032
  6. 5.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2021-2026
  7. 5.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2027-2032
  8. 5.4 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
  9. 5.4.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2032)
  11. 5.4.3 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
  16. 5.5.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2032)
  18. 5.5.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
  41. 5.7.1 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2032)
  43. 5.7.3 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2032)
  2. 6.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2032) & (k pcs)
  3. 6.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2021-2032)
  5. 6.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2032)
  2. 7.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2032) & (k pcs)
  3. 7.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2021-2032)
  5. 7.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Value Chain Analysis
  2. 8.1.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process
  5. 8.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
  8. 8.2.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers
9 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Analyzing Market Dynamics
  1. 9.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
  2. 9.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Drivers
  3. 9.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Opportunities and Challenges
  4. 9.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst